CERES BRAIN Therapeutics rescue neurons to treat brain diseases.
CERES BRAIN Therapeutics has raised $6.5M in total funding. The most recent round was Seed. The last funding was announced in January 2024.
CERES BRAIN Therapeutics's investors include ANJAC SAS, Thomas Joudinaud.
CERES BRAIN Therapeutics is headquartered in Paris, France.
CERES BRAIN Therapeutics rescue neurons to treat brain diseases.
CERES BRAIN Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CERES BRAIN Therapeutics — Funding & Investors." VCBacked, January 22, 2024, https://www.vcbacked.co/company/ceres-brain-therapeutics. Accessed August 22, 2026.
VCBacked. (2024). CERES BRAIN Therapeutics — Funding & Investors. Retrieved August 22, 2026, from https://www.vcbacked.co/company/ceres-brain-therapeutics
{{cite web |title=CERES BRAIN Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/ceres-brain-therapeutics |website=VCBacked |access-date=August 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated